pretickt

When does Johnson & Johnson report earnings?

Johnson & Johnson · end-of-day data as of Nov 13, 2026

Johnson & Johnson
JNJ · $688B
$285.75+0.8%
Nov 13, 2026 · close
$260$280SepOctNov9:3016:003 months +5.9%Nov 13 · close
▲ 6
  • ConsensusBuy · 23
  • Trendbullish
  • MAs4 of 4
  • MA20×50Golden 3d ago
  • MACD1.55
  • Sector▲ +15.9%
Neutral
  • Earnings in74d
  • RSI66
  • Support-3.5%
  • Off 52w high-0.8%
  • Volume0.8x
  • Bollingerupper half
  • News
  • 52w range$194–$288
  • ATR+2.4%
  • Off ATH-0.8%
▼ 2
  • PT$282.00 -1.3%
  • Insiders-$13.86M

Updates with the 15-min delayed price. Not a forecast or investment advice.

Johnson & Johnson JNJ reports its next earnings on Tuesday, Jan 26, 2027, before the open, an estimated date the company has not confirmed yet. Analysts expect EPS of $2.91 on revenue of $26.42B. Johnson & Johnson beat the EPS estimate in 4 of its last 8 reports, and the stock moved ±2.3% on average the session after. The last report, on Oct 13, 2026: EPS of $2.59 against $2.52 expected and revenue of $25.4B against $25.38B; the stock fell 5.7% the next session.

The stock around its reports

⇔⇕$145$189$232$276Nov 24Apr 25Sep 25Feb 26Jul 26Dec 26DEDAEADEDAAEADEADEADEDEDE

Last close $285.75 · +94.5% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q3 FY2026: Revenue +3.4% year over year, operating margin 25.1%.

RevenueFree cash flow
Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q3 FY2026
Q3 FY2026Sep 30, 2026$25.4B0.09—73.0%25.1%0.8%
Q3 FY2026Sep 27, 2026$25.4B0.09$6.36B68.1%23.0%0.8%
Q2 FY2026Jun 28, 2026$25.31B2.27$7.29B68.2%28.3%21.9%
Q1 FY2026Mar 29, 2026$24.06B2.14$1.47B66.3%26.6%21.8%
Q4 FY2025Dec 28, 2025$24.56B2.10$5.47B67.6%22.8%20.8%
Q3 FY2025Sep 28, 2025$23.99B2.12$8.38B69.6%29.6%21.5%
Q2 FY2025Jun 29, 2025$23.74B2.29$2.48B67.9%28.7%23.3%
Q1 FY2025Mar 30, 2025$21.89B4.54$3.38B66.4%28.8%50.2%